期刊文献+

制备工艺对骨架片释放的影响 被引量:4

Effects of Preparation Parameters on Drug Release from Matrices
下载PDF
导出
摘要 以盐酸氢吗啡酮为模型药物 ,制备了 6种不同类型的骨架片 ,研究了工艺参数对骨架片释放行为的影响。结果表明 :(1) HPMC与十八醇或 EC合用能明显减小压片压力对释放的影响 ;(2 )对于 HPMC亲水凝胶骨架片 ,用含1% HPMC K4 M的 5 0 %乙醇湿法制粒的效果与粉末直接压片相当 ;对于 HPMC-十八醇混合骨架片 ,湿法制粒的释药快于熔融制粒法 ;(3) HPMC-十八醇混合骨架片释放受片径或 (和 )片重改变的影响小于 HPMC- CMC- Na-十八醇混合骨架片 ;(4)包薄膜衣、制粒大小及工艺放大对 HPMC-十八醇混合骨架片的释放基本无影响。 The effects of preparation parameters on the release of hydromorphone hydrochloride from six various of matrices were investigated. The results showed that: (1) combined use of HPMC with octadecanol or EC could remarkably decrease the effect of compression force on drug release; (2) drug release from HPMC hydrocolloid matrices prepared by wet granulation method with 1% HPMC K4M in 50% ethanol was comparable to those prepared by direct powder compression procedure; drug release from combined HPMC octadecanol matrices prepared by wet granulation method was faster than those prepared by melt granulation method; (3) drug release from combined HPMC octadecanol matrices varied with tablet diameter or/and weight less than those from combined HPMC CMCNa octadecanol matrices; (4) film coating, granule size and scale up of process had little effect on drug release from combined HPMC octadecanol matrices.
作者 林晓 陈济民
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2003年第5期226-229,共4页 Chinese Journal of Pharmaceuticals
关键词 骨架片 盐酸氢吗啡酮 体外释药 matrices hydromorphone hydrochloride in vitro release
  • 相关文献

参考文献8

二级参考文献28

  • 1[1]Chidambaram N,Porter W,Flood K.Formulation and characterization of new layered diffusional matrices for zero-order sustained release[J].J Controlled Release,1998,52:149.
  • 2[2]Conte U,Maggi L,Colombo P,et al.Multi-layered hydrophilic matrices as constant release devices[J].J Controlled Release,1993,26:39.
  • 3[3]Conte U,Maggi L.Multilayer tablets as drug delivery devices[J].Pharm Tech,1998,3:174.
  • 4[4]Colombo P,Conte U,Gazzaniga A,et al.Drug release modulation by physical restrictions of matrix swelling[J].Int J Pharm,1990,63:43.
  • 5[5]Baveja SK,Rao KVR,Scingh A.Sustained release tablet formulation of diethylcarbomazine[J].Int J Pharm,1984,19:229.
  • 6[6]Kim C.Compressed donut-shaped tablets with zero-order release kinetics[J].Pharm Res,1995,12:1045.
  • 7[7]Hildgen P,McMullen JN.A new gradient matrix:formulation and characterization[J].J Controlled Release,1995,34:263.
  • 8[8]Scott DC,Hollenbeck RG.Design and manufacture of a zero-order sustained-release pellet dosage form through nonuniform drug distribution in a diffusional matrix[J].Pharm Res,1991,8:156.
  • 9Mockel JE, Lippold BC. Zero-order drug release from hydrocolloid matrices [J]. Pharm Res, 1993,10:1066.
  • 10Ford JL, Rubinstein MH, McCaul F, et al. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydmxypropylmethylcellulose matrix tablets [J]. Int J Pharm,1987,40: 223.

共引文献88

同被引文献38

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部